"name","id","instanceType","description","text","uuid:ID","label"
"OBJ1","Objective_1","OBJECTIVE","Main objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","b0b25669-951b-4c89-8cdc-8f6910fe79ec",""
"OBJ2","Objective_2","OBJECTIVE","Safety","To document the safety profile of the xanomeline TTS.","d203c3b3-2113-496b-9eea-072fe4b2553b",""
"OBJ3","Objective_3","OBJECTIVE","Behaviour","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","7096fb16-bcaf-4c28-9dec-1d265ef112c5",""
